worldwide@absin.cn
  • Sign in or Register
    My account Recent orders Wish list Address management

    Sign out

  • Cart 0
    The latest additions

      0 items in total

      Subtotal $0.00

      Go to cart
    • English
      Chinese
    爱必信(absin)官网
    爱必信(absin)官网

    000000 Citations

    Home
    Products
    Promotions
    Resources
    Product ApplicationFAQsNewsCitationsElectronic DocumentsCalculation Tools
    About us
    Contact us
    worldwide@absin.cn
    • Sign in or Register
      My account Recent orders Wish list Address management

      Sign out

    • Cart 0
      The latest additions

        0 items in total

        Subtotal $0.00

        Go to cart
      • English
        Chinese
      爱必信(absin)官网
      爱必信(absin)官网

      000000 Citations

      Home
      Products
      Promotions
      Resources
      Product ApplicationFAQsNewsCitationsElectronic DocumentsCalculation Tools
      About us
      Contact us
      HomeProduct ApplicationTechnical Characteristics and Experimental Application Guide of DNase I
      Search

      Technical Characteristics and Experimental Application Guide of DNase I

      May 19, 2026

      Clicks:76

      Share:
      Share This on facebook
      Share This on twitter
      Share This on pinterest
      Share This on linkedin
      Share This on skype
      Share This on telegram
      Share This on whatsapp
      Share This on wechat

      DNase I (Deoxyribonuclease I) is an indispensable tool enzyme in molecular biology research that can precisely degrade DNA while preserving RNA integrity. This article systematically elaborates its enzymatic properties, core applications and operational key points to provide technical references for RNA-related research.

      What is DNase I?

      DNase I is a non-specific endodeoxyribonuclease that digests single-stranded or double-stranded DNA molecules. The enzyme recognizes and cleaves phosphodiester bonds to produce monodeoxynucleotides or oligodeoxynucleotide fragments with 5'-phosphate and 3'-hydroxyl termini. Its activity strictly depends on the presence of Ca2+ and can be further activated by divalent metal ions such as Mn2+ and Mg2+.

      From a structural biology perspective, DNase I randomly cleaves any site on either DNA strand in the presence of Mg2+; under Mn2+ conditions, it cleaves both DNA strands at nearly identical sites to form blunt ends or sticky ends with 1-2 nucleotide overhangs. This metal ion-dependent cleavage characteristic provides flexibility for experimental design.

      What are the core properties of DNase I?

      • High purity and RNase-free contamination: High-quality DNase I products are strictly purified to ensure no RNase activity. The quality control standard stipulates that when 5 U of enzyme reacts with 1.6 μg MS2 RNA at 37°C for 4 hours, the RNA electrophoresis band should remain unchanged, which is the core indicator for evaluating product applicability.
      • Clear activity definition: One unit (U) is defined as the amount of enzyme required to completely degrade 1 μg pBR322 DNA in 10 minutes at 37°C. This plasmid substrate-based definition is highly relevant to practical applications, allowing researchers to accurately calculate the dosage.
      • Metal ion dependence: 5 mM Ca2+ protects enzyme molecules from hydrolysis and maintains their stability. The cleavage patterns regulated by different metal ions provide differentiated tools for molecular cloning and end modification.

      In which experiments must DNase I be used?

      • Removal of DNA contamination from RNA samples: Genomic DNA contamination in extracted RNA seriously affects the quantitative accuracy of RT-qPCR and leads to false-positive results. DNase I treatment before reverse transcription can completely eliminate DNA interference and ensure the reliability of Ct values.
      • Purification of in vitro transcription products: mRNA or siRNA synthesized by in vitro transcription may retain DNA templates, which can trigger immune responses or interfere with functional studies if introduced into cells. DNase I treatment specifically degrades DNA templates while preserving intact RNA products.
      • RNase Protection Assay: In the RNase Protection Assay (RPA), DNase I is used to remove probe DNA that is not hybridized to RNA, retaining only RNA-DNA heteroduplexes to improve detection specificity.
      • Chromatin accessibility analysis: In DNase-seq or ATAC-seq experiments, DNase I is used to cleave open chromatin regions, and accessible genomic loci are identified by sequencing, which is a key step in epigenetic research.
      • Ribosome profiling: In ribosome footprinting experiments, DNase I is used to remove mRNA fragments not protected by ribosomes, retaining only RNA fragments covered by ribosomes for translatome research.

      How to establish a standard DNase I digestion system?

      Reaction System Preparation

      In an RNase-free reaction tube, prepare a 10 μL reaction mixture as follows: X μg RNA sample, 1 μL 10× DNase I Buffer, DNase I (5 U/μL) added at 1 U per μg RNA (at least 1 U for RNA less than 1 μg), and finally make up to 10 μL with RNase-free ddH₂O.

      Digestion Reaction Conditions

      Incubation at 37°C for 15 minutes is the standard condition. For samples with severe DNA contamination, it can be extended to 30 minutes, but beware that prolonged incubation may increase the risk of non-specific RNA degradation.

      Enzyme Inactivation Treatment

      After digestion, add stop buffer and heat at 65°C for 10 minutes to completely inactivate DNase I. To prevent RNA degradation at this stage, EDTA must be added to a final concentration of 5 mM to chelate metal ions, ensuring complete enzyme inactivation without damaging RNA.

      Subsequent Operation Connection

      The inactivated sample can be directly used for reverse transcription or library construction without additional purification. For long-term storage, phenol-chloroform extraction followed by ethanol precipitation is recommended to obtain purer RNA.

      What are the key precautions for using DNase I?

      • Precise control of enzyme concentration: 1 U of enzyme per μg RNA is the empirically optimized optimal ratio. Insufficient enzyme leads to incomplete DNA removal, while excessive enzyme increases the risk of RNase contamination. For precious samples, small-scale preliminary experiments are recommended to determine the optimal enzyme dosage.
      • RNA quality monitoring: The integrity of digested RNA should be detected by agarose gel electrophoresis or Agilent Bioanalyzer. Only RNA with clear 28S and 18S bands and RIN value >7.0 can be used for subsequent experiments.
      • Product selection: DNase I itself has no RNase activity, but commercial products may contain trace RNase contamination, so RNase-free grade products with strict quality control must be selected.
      • Matching reaction buffer: The supporting 10× DNase I Buffer, which contains essential components such as Ca2+, must be used. Using other buffers may significantly reduce enzyme activity or cause non-specific cleavage.
      • Avoid cross-contamination: DNase I can tolerate repeated freeze-thaw cycles, but it is recommended to aliquot according to experimental needs at first use to avoid frequent temperature changes affecting long-term stability. Special RNase-free consumables and reagents should be used during operation.

      How to evaluate the effect of DNase I treatment?

      • Negative control setup: In RT-qPCR experiments, set up a No Reverse Transcriptase (NRT) control, in which DNase I-treated RNA is directly amplified by PCR. If the Ct value >35 or no amplification occurs, it proves that DNA removal is complete; if obvious amplification occurs, the digestion conditions need to be optimized.
      • Gel electrophoresis verification: Perform agarose gel electrophoresis on RNA samples before and after treatment. If the bands are clear and there is no smear-like DNA background after digestion, it indicates a significant effect. Housekeeping genes can also be amplified with specific primers to compare the product amounts before and after digestion.
      • Functional validation: In RNA-seq library construction, calculate the distribution of reads on the genome through alignment analysis. If most reads can be mapped to transcripts rather than intergenic regions, it indicates that DNA contamination is effectively controlled.
      • Reference gene test: Select a reference gene that can be amplified from both genomic DNA and cDNA, such as GAPDH, and design intron-spanning primers. After DNase I treatment, genomic DNA should not be amplified, and only cDNA produces specific bands.

      DNase I is a critical quality control step in RNA research. Correct understanding of its enzymatic properties, establishment of a standardized digestion process, and strict verification of treatment effects can effectively avoid experimental deviations caused by DNA contamination and ensure the accuracy and repeatability of RNA-related research data.

      Absin DNase I Recommendation

      Cat. No. Product Name Size
      abs60539 DNase I 1KU/5KU
      【Disclaimer】This article is derived from publicly available online information and generated by AI. If it inadvertently infringes on rights, please contact us promptly, and we will cooperate with the processing immediately without assuming any legal liability.


      Contact Absin

      Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

      Absin Bioscience Inc.

      worldwide@absin.cn
      Follow us on Facebook: Absin Bio
       

      Ordering Details

      Email: worldwide@absin.cn

      Thanks for your interesting of our products, we will reply to you in 1-2 working days.

      • Products
      • Resources
      • Product Application
      • Calculation Tools
      • FAQs
      • Citations
      • Electronic Documents
      • About us
      • Company Profile
      • Ordering Tools
      • Customer Support
      • Contact us
      Email: worldwide@absin.cn
      picture invalid picture invalid
      ICP:16001690 Absin Bioscience Inc.All rights reserved.